Literature DB >> 1315716

Detailed analysis of an amplified region at chromosome 11q13 in malignant tumors.

A Tanigami1, T Tokino, K Takita, M Ueda, F Kasumi, Y Nakamura.   

Abstract

We have examined the amplification unit at chromosome band 11q13 in 12 primary tumors and one cancer cell line (A431) with 15 DNA markers. The amplified region and size varied from one tumor to another; the smallest amplicon was estimated to be 700 kb long and the largest was 4.5 Mb long at maximum, on the basis of a physical map. Furthermore, the DNA amplified in tumors was not always continuous, because in three cases one locus within the amplicon was not amplified. The amplified region common to all 13 cancers consisted of 500 kb of DNA which incorporated eight defined loci (BCL-1, cCI11-524, cCI11-283, cCI11-234, HBI-1, cCI11-454, HSTF1, and INT2). As two of them, cCI11-524 and cCI11-454, were found to contain DNA sequences conserved in other species, one or both of these loci might encode the gene(s) that may be associated with progression of these tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315716     DOI: 10.1016/0888-7543(92)90196-y

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  4 in total

1.  Cyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression.

Authors:  S D Worsley; B A Jennings; K H Khalil; M Mole; A C Girling
Journal:  Clin Mol Pathol       Date:  1996-02

2.  Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress.

Authors:  Zheming Lu; Lei Zhou; Patrick Killela; Ahmed B Rasheed; Chunhui Di; William E Poe; Roger E McLendon; Darell D Bigner; Christopher Nicchitta; Hai Yan
Journal:  Cancer Res       Date:  2009-11-17       Impact factor: 12.701

3.  Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma.

Authors:  Bao-Zhu Yuan; Xiaoling Zhou; Drazen B Zimonjic; Marian E Durkin; Nicholas C Popescu
Journal:  J Mol Diagn       Date:  2003-02       Impact factor: 5.568

4.  The "Spot 14" gene resides on the telomeric end of the 11q13 amplicon and is expressed in lipogenic breast cancers: implications for control of tumor metabolism.

Authors:  J T Moncur; J P Park; V A Memoli; T K Mohandas; W B Kinlaw
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.